
Introduction
OEM, ODM, private label and CDMO are common terms in supplement manufacturing, but suppliers do not always use them in exactly the same way. The safest approach is to compare the work included, the decisions already completed by the buyer and the responsibilities assigned to each party.
In practical terms, OEM usually starts with a more defined specification, ODM provides more product-development support, private label focuses on bringing a product and package to market under the buyer’s brand, and CDMO covers a broader coordinated development and manufacturing program. The right path depends on how much of the product has already been decided.
Quick comparison
| Model | Typical starting point | Main focus | Suitable buyer |
|---|---|---|---|
| OEM | Defined formula, specification or reference | Manufacturing and packaging against an agreed scope | Established brands and buyers with technical input |
| ODM | Product concept or ingredient direction | Formula, dosage form and product-development coordination | Brands that need more development support |
| Private label | Market-facing product and brand plan | Product selection, packaging and label coordination | New brands, distributors and ecommerce sellers |
| CDMO | Broader development program | End-to-end coordination from concept through manufacturing | Buyers with complex or multi-stage projects |
This table is a starting point, not a universal legal definition. The written project scope is more important than the label used in a sales presentation.
What is supplement OEM?
OEM stands for original equipment manufacturing. In a supplement project, it usually means that the buyer already has a relatively defined product direction, formula, specification or reference and needs a manufacturing partner to review feasibility, production and packaging.
An OEM discussion normally requires:
- a formula, target specification or clear reference product;
- dosage form and serving design;
- estimated order quantity;
- packaging and pack-count requirements;
- testing and document expectations;
- target market and delivery requirements.
OEM does not mean that a manufacturer should accept a buyer’s formula without review. Ingredient properties, dosage-form limits, production process, packaging compatibility and target-market considerations still need to be evaluated.
Choose OEM when:
- your team already controls the formula or specification;
- you know the required dosage form and serving size;
- packaging and quantity are mostly defined;
- you need a project-specific manufacturing quotation;
- you can provide or approve the required technical inputs.
What is supplement ODM?
ODM stands for original design manufacturing. It is generally appropriate when the buyer has a commercial direction but needs more support defining the finished product.
The buyer may know:
- the target consumer;
- preferred ingredient or product category;
- target retail price or channel;
- dosage-form preference;
- reference products;
- destination market.
The manufacturer or development team then helps organize decisions around formula direction, dosage form, serving design, flavor or appearance where relevant, packaging and sampling.
ODM is not a substitute for buyer decisions. The brand owner must still approve the product direction, market positioning, label, commercial terms and destination-market plan.
Choose ODM when:
- you have a product idea but not a final formula;
- you need help comparing dosage forms;
- you need a structured route from concept to sample;
- packaging and label requirements are not fully defined;
- your team can give feedback and approve staged decisions.
What is private label supplement manufacturing?
Private label describes a product sold under the buyer’s brand. The underlying cooperation may use an existing product direction, a modified specification or a custom-development process.
A private label project often includes:
- product-direction selection;
- brand and label coordination;
- bottle, pouch, blister, sachet or carton planning;
- pack-count decisions;
- quotation and sample discussion;
- production and shipment follow-up.
Private label does not automatically mean “ready stock,” “low MOQ” or “instant launch.” These conditions depend on the actual product, packaging components, testing, document requirements and production plan.
Choose private label when:
- the commercial priority is launching under your own brand;
- you need help connecting product, package and label decisions;
- you are open to evaluating an existing product direction;
- you can confirm your destination-market and channel requirements.
What is a supplement CDMO?
CDMO stands for contract development and manufacturing organization. It describes a broader relationship that combines development and manufacturing activities across multiple stages.
A CDMO-style program may coordinate:
- product concept and requirement collection;
- formula and dosage-form review;
- prototype or sample iterations;
- packaging-development coordination;
- specification and quality-document planning;
- manufacturing and project scheduling;
- scale-up and lifecycle follow-up.
CDMO is useful when the project requires structured coordination rather than a single transactional quotation. Buyers should still confirm which development, testing, regulatory, packaging and manufacturing activities are included.
Choose CDMO when:
- the product requires multiple development stages;
- several technical and commercial workstreams must be coordinated;
- your team wants a documented path from concept to production;
- the project may involve continued development after the first order.
Five questions that identify the right model
1. Do you have a finished formula?
If yes, start with OEM feasibility review. If no, ODM or CDMO may be more appropriate.
2. Is the dosage form fixed?
If the buyer is still comparing softgels, hard capsules, tablets or powders, the project requires more development discussion before a comparable quotation can be prepared.
3. Is packaging already specified?
If packaging materials, pack count, label and carton remain open, include packaging coordination in the project scope.
4. Does the product require several sample rounds?
A single reference sample is different from a staged development program. Clarify the purpose, number and approval criteria for each sample.
5. Who will confirm destination-market requirements?
The manufacturer may provide available product, quality and export information, but the buyer should identify the local importer, consultant or responsible party that will confirm classification, registration, label and claim requirements.
Project responsibility matrix
| Decision | Buyer responsibility | Manufacturer or project-team role |
|---|---|---|
| Product concept | Define business goal and target consumer | Review manufacturability and identify missing inputs |
| Formula | Approve direction and commercial positioning | Coordinate feasibility and specification discussion |
| Target market | Identify destination and local requirements | Provide available information for project review |
| Packaging | Approve format, count and artwork | Coordinate production and component requirements |
| Label and claims | Obtain appropriate market review and final approval | Organize available product information and print scope |
| Quotation | Confirm comparable project scope | Price the confirmed scope and list exclusions |
| Sample | Define approval criteria and give feedback | Coordinate the agreed sample scope |
| Production | Approve specification and commercial terms | Schedule and follow the confirmed manufacturing scope |
Common mistakes when choosing a cooperation model
Asking for an OEM price with an ODM-level brief
“Magnesium capsules with my logo” is not enough for a comparable OEM quotation. The ingredient form, amount, capsule count, packaging, quantity and market still need clarification.
Treating private label as a fixed product
Private label describes the brand arrangement, not one universal level of customization. Ask what can be changed and what remains fixed.
Assuming CDMO includes every service
The term does not prove that regulatory filing, clinical work, ingredient sourcing, packaging design or market approval is included. Require a written scope.
Selecting only by MOQ
Quantity matters, but it must be reviewed together with product fit, packaging, documentation, price structure and repeat-order potential.
How Bodakang Bio organizes cooperation paths
Bodakang Bio supports overseas B2B buyers with product and dosage-form discussion, quotation communication, packaging planning and project follow-up. Guangzhou Changshengkang Biotechnology Co., Ltd. may provide additional manufacturing and technical support under confirmed cooperation terms. Final capability, documents, MOQ, pricing, samples and timing are confirmed against the individual project.
Review the current OEM/ODM service scope, CDMO solutions, private label support and product catalog.
Frequently asked questions
Is ODM better than OEM?
Neither is automatically better. OEM is efficient when the specification is already defined. ODM is more appropriate when the buyer needs product-development support.
Can a startup use CDMO services?
Potentially, but the development scope and commercial requirements must fit the project. A startup with a simple product direction may be better served by a focused ODM or private label path.
Is private label the same as ODM?
Not exactly. Private label describes selling the product under the buyer’s brand. The product may be based on an existing direction or developed through an ODM process.
When can a manufacturer provide a final quotation?
After enough of the formula, dosage form, quantity, packaging, testing, documentation and commercial scope has been confirmed.
Choose the right starting point
Send the product direction, current formula status, dosage-form preference, target market, estimated quantity and packaging plan. Bodakang Bio can identify whether the project should begin as OEM, ODM, private label or a broader CDMO discussion.
Official sources reviewed
Source pages checked on 26 September 2026. Market requirements must be checked again for the specific product before launch.
- U.S. FDA: Dietary Supplements · Date not stated on the current page
- U.S. FDA: Dietary Supplements Guidance Documents & Regulatory Information · Date not stated on the current page
- Singapore HSA: Regulatory overview of health supplements · Updated 9 September 2026






